A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiologya
Miller Jm(Centers for Disease Control and Prevention), Joseph D. Yao(Purdue University West Lafayette), Sam R. Telford(Tufts University), Joseph D. Schwartzman(Dartmouth–Hitchcock Medical Center), Robert C. Jerris(Children's Healthcare of Atlanta), James W. Snyder(University of Louisville), Barbara Robinson-Dunn(Beaumont Health), Karen C. Carroll(Johns Hopkins University), Sandra S. Richter(University of Tübingen), Melvin P. Weinstein(Rutgers, The State University of New Jersey), Robin Patel(Mayo Clinic in Arizona), Kimberle C. Chapin(Providence College), Sheldon Campbell(Yale University), Elitza S. Theel(Mayo Clinic), Sue C. Kehl(Medical College of Wisconsin), Richard B. Thomson(NorthShore University HealthSystem), Peter H. Gilligan(University of North Carolina at Chapel Hill), Matthew J. Binnicker(Mayo Clinic), Mark D. Gonzalez(Children's Healthcare of Atlanta), Bobbi S. Pritt(WinnMed)
Cited by 618
Related Papers
The Clinical Significance of Positive Blood Cultures: A Comprehensive Analysis of 500 Episodes of Bacteremia and Fungemia in Adults. I. Laboratory and Epidemiologic Observations
|Clinical Infectious Diseases|1983|754
Comparison of Levator Ani Muscle Defects and Function in Women With and Without Pelvic Organ Prolapse
|Obstetrics and Gynecology|2007|703
A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2013 Recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)a
|Clinical Infectious Diseases|2013|591
Classification, Identification, and Clinical Significance of Proteus, Providencia, and Morganella
|Clinical Microbiology Reviews|2000|587
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
|New England Journal of Medicine|2021|553